WINNER! Best Seed Stage Company 2019
WINNER! Best of Oregon 2019
Sparrow Pharmaceuticals is developing next-generation corticosteroid (CS) products that are expected to have fewer side effects than, but the same efficacy as, current generation CS (e.g., prednisone).
Combinations of our proprietary drugs and CS have potential to be the first medicines that offer strong efficacy, safety, convenience, and cost-effectiveness to millions of patients who today rely on long-term CS therapy to control autoimmune diseases, blood cancers, and transplanted organ rejection.
Sparrow Pharmaceuticals appreciates institutional support from both Chicago and Portland.